Tonix Pharmaceuticals
TNXP
#8315
Rank
HK$1.80 B
Marketcap
HK$152.89
Share price
0.56%
Change (1 day)
9.18%
Change (1 year)

Revenue for Tonix Pharmaceuticals (TNXP)

Revenue in 2025 (TTM): HK$80.22 Million

According to Tonix Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is HK$80.17 Million. In 2024 the company made a revenue of HK$78.36 Million an increase over the revenue in the year 2023 that were of HK$60.66 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Tonix Pharmaceuticals from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$80.22 M2.38%
2024 HK$78.36 M29.17%
2023 HK$60.66 M
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Aerie Pharmaceuticals
AERI
HK$1.66 B 1,977.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
HK$2.00 B 2,400.74%๐Ÿ‡บ๐Ÿ‡ธ USA